Bausch Health
BHC
#4085
Rank
A$3.56 B
Marketcap
$9.69
Share price
-3.45%
Change (1 day)
-25.49%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.00

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.18. In 2022 the company made an earnings per share (EPS) of -$0.98 an increase over its 2021 EPS that were of -$4.18.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.00309.5%
2022-$0.98-76.64%
2021-$4.1868.45%
2020-$2.48-68.91%
2019-$7.99-57.11%
2018-$18.62-272.22%
2017$10.81-199.29%
2016-$10.89798.7%
2015-$1.21-128.31%
2014$4.28-204.62%
2013-$4.09602.7%
2012-$0.58-171.15%
2011$0.82-143.96%
2010-$1.86-206.57%
2009$1.75-11.2%
2008$1.972.46%
2007$1.92-7.58%
2006$2.08-14.29%
2005$2.4254%
2004$1.57-500%
2003-$0.39-141.67%
2002$0.94-4.76%
2001$0.99-175%
2000-$1.32-268%
1999$0.7914.94%
1998$0.6820.83%
1997$0.5753.83%
1996$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.57-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.42-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA